| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
1 company
Knowles Julius is a Director at Keros Therapeutics, Inc.. Recent SEC Form 4 filings include 0 buys and 130 sells.
Estimated insider holdings value: $1.7M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jan 5, 2022 | KROS Keros Therapeutics, Inc. | Director | Sell | 47,651 | $57.84 | $2,756,115.99 | -0.7% | +12.3% | -18.8% | |
| Dec 2, 2021 | KROS Keros Therapeutics, Inc. | Director | Sell | 47,651 | $54.09 | $2,577,375.56 | -0.9% | -4.2% | -5.6% | |
| Nov 3, 2021 | KROS Keros Therapeutics, Inc. | Director | Sell | 47,651 | $42.12 | $2,007,129.32 | -1.1% | +18.7% | +21.4% | |
| Oct 20, 2021 | KROS Keros Therapeutics, Inc. | Director | Sell | 8,598 | $38.20 | $328,440.86 | -0.3% | +26.6% | +15.1% | |
| Oct 18, 2021 | KROS Keros Therapeutics, Inc. | Director | Sell | 26,367 | $38.56 | $1,016,652.69 | -0.6% | +27.6% | +20.7% | |
| Oct 5, 2021 | KROS Keros Therapeutics, Inc. | Director | Sell | 12,686 | $40.10 | $508,754.95 | -0.6% | +49.0% | +0.5% | |
| Sep 27, 2021 | KROS Keros Therapeutics, Inc. | Director | Sell | 95,302 | $41.17 | $3,924,003.27 | -3.9% | +34.3% | -19.2% | |
| Jul 2, 2021 | KROS Keros Therapeutics, Inc. | Director | Sell | 47,652 | $41.31 | $1,968,351.60 | -1.1% | -3.5% | -31.5% | |
| Jun 7, 2021 | KROS Keros Therapeutics, Inc. | Director | Sell | 19,192 | $48.85 | $937,597.73 | -0.3% | -34.7% | -35.9% | |
| Jun 3, 2021 | KROS Keros Therapeutics, Inc. | Director | Sell | 28,236 | $49.71 | $1,403,553.38 | -0.3% | -29.7% | -28.0% |